BioAndrew is an Investment Director in Inflexion’s buyout team, his responsibilities include appraising and executing new transactions and originating new mid-market opportunities. Andrew was involved in our investment in Medivet.Prior to joining Inflexion in 2016, Andrew was an Investment Director at Octopus Healthcare. Andrew was involved in creating a new entrant to the UK private hospital market, in addition to th ....
Work Experience
Current
Past